Literature DB >> 10027670

The association of functional gastrointestinal disorders and fibromyalgia.

L Chang1.   

Abstract

Previous epidemiological studies have confirmed the clinical impression that functional gastrointestinal disorders typically overlap with fibromyalgia (FM) in the same patient, suggesting a common etiology. FM syndrome occurs in up to 60% of patients with functional bowel disorders. Up to 50% of patients with a diagnosis of FM syndrome complain of symptoms characteristic of functional dyspepsia and 70% have symptoms of IBS. These two conditions have common clinical characteristics: (1) the majority of patients associate stressful life events with the initiation or exacerbation of symptoms, (2) the majority of patients complain of disturbed sleep and fatigue, (3) psychotherapy and behavioral therapies are efficacious in treating symptoms, and (4) low-dose tricyclic antidepressant medication can improve symptoms. Despite these similarities, their perceptual responses to both somatic and visceral stimuli differ. While FM patients characteristically exhibit somatic hyperalgesia, IBS patients without coexistent FM have somatic hypoalgesia to mechanical stimuli. Visceral distention studies have also demonstrated perceptual alterations in patients with IBS and FM although these findings appear to differ in the two conditions. Further studies will help explore the mechanisms which are responsible for the similarities and differences in clinical symptoms and physiologic parameters seen in IBS and FM.

Entities:  

Mesh:

Year:  1998        PMID: 10027670     DOI: 10.1080/11024159850191210

Source DB:  PubMed          Journal:  Eur J Surg Suppl        ISSN: 1102-416X


  13 in total

1.  Extraintestinal symptoms in irritable bowel syndrome and inflammatory bowel diseases: nature, severity, and relationship to gastrointestinal symptoms.

Authors:  Joseph Zimmerman
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

2.  Dietary aspects in fibromyalgia patients: results of a survey on food awareness, allergies, and nutritional supplementation.

Authors:  Laura-Isabel Arranz; Miguel-Ángel Canela; Magda Rafecas
Journal:  Rheumatol Int       Date:  2011-07-22       Impact factor: 2.631

3.  Melatonin: a novel treatment for IBS?

Authors:  S Elsenbruch
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

Review 4.  An insight into the gastrointestinal component of fibromyalgia: clinical manifestations and potential underlying mechanisms.

Authors:  Mahmoud Slim; Elena Pita Calandre; Fernando Rico-Villademoros
Journal:  Rheumatol Int       Date:  2014-08-14       Impact factor: 2.631

5.  Coexistence of Alterations of Gastrointestinal Function and Mechanical Allodynia in the Reserpine-Induced Animal Model of Fibromyalgia.

Authors:  Masayuki Uchida; Orie Kobayashi; Miku Yoshida; Machiko Miwa; Reina Miura; Hiroko Saito; Yukinori Nagakura
Journal:  Dig Dis Sci       Date:  2019-03-14       Impact factor: 3.199

6.  Prevalence of irritable bowel syndrome and depression in fibromyalgia.

Authors:  Jayde E Kurland; Walter J Coyle; Anne Winkler; Elizabeth Zable
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

Review 7.  From Hans Selye's discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases.

Authors:  Yvette Taché; Stefan Brunnhuber
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

8.  Impact of sleep dysfunction on anorectal motility in healthy humans.

Authors:  Tso-Tsai Liu; Chih-Hsun Yi; Chien-Lin Chen; William C Orr
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

9.  Overlap in patients with dyspepsia/functional dyspepsia.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Neurogastroenterol Motil       Date:  2014-09-26       Impact factor: 4.924

Review 10.  Fibromyalgia: the gastrointestinal link.

Authors:  Daniel J Wallace; David S Hallegua
Journal:  Curr Pain Headache Rep       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.